Lupin Ltd

  • BSE Code : 500257
  • NSE Symbol : LUPIN
  • ISIN : INE326A01037
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 2,071.35 28.35(1.39%)

Open Price ()

2,040.95

Prev. Close ()

2,043.00

Volume (No’s)

410,403

Market Cap ()

94,493.93

Low Price ()

2,034.00

High Price ()

2,077.20

 

Board Meetings

Start Date End Date Purpose
22-Oct-2024 07-Nov-2024 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2024 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024. Read less.. (As Per BSE Announcement Dated on 22.10.2024) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024. (As Per BSE Announcement Dated on: 07/11/2024)
23-Jul-2024 06-Aug-2024 LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2024 and other business matters.
22-Apr-2024 06-May-2024 LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 ,inter alia, to consider and approve audited financial results of the Company for the quarter and year-ended March 31, 2024 and recommend dividend, if any. Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31, 2024 And Recommend Final Dividend @ 400% i.e. Rs. 8/- Per Equity Share Of The Face Value of Rs. 2/- Each For The Year Ended March 31, 2024. Appointment of Mr. Jeffrey Kindler and Mr. Alfonso Zulueta as Independent Directors of the Company effective May 6, 2024. (As Per BSE Announcement Dated on: 06/05/2024)
22-Mar-2024 22-Mar-2024 The Company plans to carve out, its trade generics business in India, as a going concern, on a slump sale basis, to Lupin Life Sciences Limited, wholly owned subsidiary of the Company.
24-Jan-2024 07-Feb-2024 LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine-months ended December 31 2023. Unaudited Financial Results for the quarter and nine-months ended December 31, 2023. (As per BSE Announcement Dated on 07/02/2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)